Pulmagen Therapeutics (Inflammation) Limited Patent applications |
Patent application number | Title | Published |
20140248357 | Respiratory Disease Treatment - A pharmaceutical composition adapted for pulmonary administration by inhalation is described, wherein the composition comprises a glitazone and one or more pharmaceutically acceptable carriers and/or excipients, wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer, and wherein the glitazone is pioglitazone or rosiglitazone or a pharmaceutically acceptable salt thereof, and wherein the glitazone is in the form of microparticles. | 09-04-2014 |
20120264787 | Respiratory Disease Treatment - There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit. | 10-18-2012 |
20120041043 | Sulfonamide Compounds for the Treatment of Respiratory Disorders - Compounds of formula (I) are agonists of PPARĪ³, useful for the treatment of respiratory disease; formula (I): wherein R | 02-16-2012 |